AR218643A1 - Procedimiento para preparar 3-(4-fenoxi-metil-piperidino)-propoxi derivados de indol,indazol,bezimidazol y benzotriazol y sus sales - Google Patents

Procedimiento para preparar 3-(4-fenoxi-metil-piperidino)-propoxi derivados de indol,indazol,bezimidazol y benzotriazol y sus sales

Info

Publication number
AR218643A1
AR218643A1 AR269873A AR26987377A AR218643A1 AR 218643 A1 AR218643 A1 AR 218643A1 AR 269873 A AR269873 A AR 269873A AR 26987377 A AR26987377 A AR 26987377A AR 218643 A1 AR218643 A1 AR 218643A1
Authority
AR
Argentina
Prior art keywords
propoxi
bezimidazole
indazol
benzotriazol
indol
Prior art date
Application number
AR269873A
Other languages
English (en)
Spanish (es)
Original Assignee
Boehringer Mannheim Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19762651574 external-priority patent/DE2651574A1/de
Priority claimed from DE19772737630 external-priority patent/DE2737630A1/de
Application filed by Boehringer Mannheim Gmbh filed Critical Boehringer Mannheim Gmbh
Application granted granted Critical
Publication of AR218643A1 publication Critical patent/AR218643A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
    • C07D231/56—Benzopyrazoles; Hydrogenated benzopyrazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AR269873A 1976-11-12 1977-11-07 Procedimiento para preparar 3-(4-fenoxi-metil-piperidino)-propoxi derivados de indol,indazol,bezimidazol y benzotriazol y sus sales AR218643A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19762651574 DE2651574A1 (de) 1976-11-12 1976-11-12 Ein neues aminopropanol-derivat und verfahren zu dessen herstellung
DE19772737630 DE2737630A1 (de) 1977-08-20 1977-08-20 Neue aminopropanolderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel

Publications (1)

Publication Number Publication Date
AR218643A1 true AR218643A1 (es) 1980-06-30

Family

ID=25771134

Family Applications (3)

Application Number Title Priority Date Filing Date
AR269873A AR218643A1 (es) 1976-11-12 1977-11-07 Procedimiento para preparar 3-(4-fenoxi-metil-piperidino)-propoxi derivados de indol,indazol,bezimidazol y benzotriazol y sus sales
AR275657A AR221081A1 (es) 1976-11-12 1979-02-28 Procedimiento para preparar derivados de fenoximetil-piperidino-propoxi-indol
AR275655A AR221868A1 (es) 1976-11-12 1979-02-28 Un procedimiento para preparar 3-(4-fenoxi-metil-piperidino)-propoxi derivados de indol,indazol,benzimidazol y benzotriazol y sus sales

Family Applications After (2)

Application Number Title Priority Date Filing Date
AR275657A AR221081A1 (es) 1976-11-12 1979-02-28 Procedimiento para preparar derivados de fenoximetil-piperidino-propoxi-indol
AR275655A AR221868A1 (es) 1976-11-12 1979-02-28 Un procedimiento para preparar 3-(4-fenoxi-metil-piperidino)-propoxi derivados de indol,indazol,benzimidazol y benzotriazol y sus sales

Country Status (23)

Country Link
US (1) US4146630A (fi)
JP (1) JPS5363385A (fi)
AR (3) AR218643A1 (fi)
AT (1) AT361476B (fi)
AU (1) AU510284B2 (fi)
CA (1) CA1086740A (fi)
CH (3) CH636099A5 (fi)
CS (1) CS228106B2 (fi)
DD (1) DD133801A5 (fi)
DK (1) DK500677A (fi)
ES (2) ES472746A1 (fi)
FI (1) FI62077C (fi)
FR (1) FR2370744A1 (fi)
GB (1) GB1541547A (fi)
HU (1) HU177410B (fi)
IL (1) IL53323A (fi)
IT (1) IT1087490B (fi)
LU (1) LU78498A1 (fi)
NL (1) NL7712220A (fi)
PL (2) PL112683B1 (fi)
SE (1) SE7712720L (fi)
SU (2) SU826955A3 (fi)
YU (3) YU266477A (fi)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4314943A (en) * 1977-07-13 1982-02-09 Mead Johnson & Company Heterocyclic substituted aryloxy 3-indolyl-tertiary butylaminopropanols
US4495352A (en) * 1979-02-13 1985-01-22 Mead Johnson & Company Heterocyclic substituted aryloxy 3-indolyl-tertiary butylaminopropanols
DE2905876A1 (de) * 1979-02-16 1980-08-28 Boehringer Mannheim Gmbh Neue piperidinopropylderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE2922084A1 (de) * 1979-05-31 1980-12-11 Boehringer Mannheim Gmbh Neue aminopropanol-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE3200304A1 (de) * 1981-01-16 1982-08-26 Sandoz-Patent-GmbH, 7850 Lörrach 3-aminopropoxyaryl-derivate, ihre herstellung und sie enthaltende arzneimittel
WO1985004580A1 (en) * 1984-04-09 1985-10-24 American Hospital Supply Corporation Pharmaceutical composition and method for treatment or prophylaxis of cardiac disorders
FR2574795B1 (fr) * 1984-12-18 1987-11-20 Ile De France Nouveau procede industriel de synthese du n-((1'-allyl 2'-pyrrolidinyl) methyl) 2-methoxy 4,5-azimido benzamide
US5627196A (en) * 1995-01-17 1997-05-06 Eli Lilly And Company Compounds having effects on serotonin-related systems
US5614523A (en) * 1995-01-17 1997-03-25 Eli Lilly And Company Compounds having effects on serotonin-related systems
US5576321A (en) * 1995-01-17 1996-11-19 Eli Lilly And Company Compounds having effects on serotonin-related systems
US5741789A (en) 1995-01-17 1998-04-21 Eli Lilly And Company Compounds having effects on serotonin-related systems
US5789402A (en) * 1995-01-17 1998-08-04 Eli Lilly Company Compounds having effects on serotonin-related systems
ZA9610736B (en) * 1995-12-22 1997-06-27 Warner Lambert Co 2-Substituted piperidine analogs and their use as subtypeselective nmda receptor antagonists
WO2010059393A1 (en) * 2008-10-30 2010-05-27 Janssen Pharmaceutica Nv Serotonin receptor modulators
US8575364B2 (en) * 2008-10-30 2013-11-05 Janssen Pharmaceutica Nv Modulators of serotonin receptor

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB925429A (en) * 1960-04-01 1963-05-08 Irwin Neisler & Co Indole derivatives
US3699123A (en) * 1970-03-24 1972-10-17 Sandoz Ltd 4-(3-amino-2-hydroxy-propoxy) indole derivatives
BE794333A (fr) * 1972-01-20 1973-07-19 Wyeth John & Brother Ltd Composes heterocycliques azotes therapeutiques
JPS48103590A (fi) * 1972-04-13 1973-12-25
JPS6024100B2 (ja) * 1975-02-11 1985-06-11 ベーリンガー・マンハイム・ゲゼルシヤフト・ミツト・ベシユレンクテル・ハフツング アミノプロパノ−ル−誘導体の製法
DE2549568C3 (de) * 1975-11-05 1981-10-29 Bayer Ag, 5090 Leverkusen 2,6-Dimethyl-3-methoxycarbonyl-4- (2'-nitrophenyl)-1,4-dihydropyridin-5- carbonsäureisobutylester, mehrere Verfahren zu seiner Herstellung sowie ihn enthaltende Arzneimittel

Also Published As

Publication number Publication date
FR2370744B1 (fi) 1981-06-12
AT361476B (de) 1981-03-10
YU128983A (en) 1984-04-30
PL201997A1 (pl) 1979-03-12
IT1087490B (it) 1985-06-04
IL53323A0 (en) 1978-01-31
ES472746A1 (es) 1979-02-16
AU3046677A (en) 1979-05-17
SE7712720L (sv) 1978-05-13
FI62077C (fi) 1982-11-10
PL110782B1 (en) 1980-07-31
FI773346A (fi) 1978-05-13
YU266477A (en) 1984-02-29
GB1541547A (en) 1979-03-07
AR221868A1 (es) 1981-03-31
FR2370744A1 (fr) 1978-06-09
PL112683B1 (en) 1980-10-31
IL53323A (en) 1981-12-31
CH643554A5 (de) 1984-06-15
CH639086A5 (de) 1983-10-31
CH636099A5 (de) 1983-05-13
JPS5363385A (en) 1978-06-06
NL7712220A (nl) 1978-05-17
ES472747A1 (es) 1979-02-16
AU510284B2 (en) 1980-06-19
ATA808277A (de) 1980-08-15
HU177410B (en) 1981-10-28
SU890975A3 (ru) 1981-12-15
US4146630A (en) 1979-03-27
FI62077B (fi) 1982-07-30
LU78498A1 (fi) 1979-02-02
JPS6341910B2 (fi) 1988-08-19
AR221081A1 (es) 1980-12-30
DD133801A5 (de) 1979-01-24
CS228106B2 (en) 1984-05-14
YU128883A (en) 1984-04-30
DK500677A (da) 1978-05-13
CA1086740A (en) 1980-09-30
SU826955A3 (ru) 1981-04-30

Similar Documents

Publication Publication Date Title
AR228444A1 (es) Procedimiento para preparar derivados de 5-bencil-tiazolidin-2,4-diona y sus sales
ES487464A0 (es) Procedimiento de preparacion de nuevos derivados aldehidos peptidil-argininos y de sus sales
AR218643A1 (es) Procedimiento para preparar 3-(4-fenoxi-metil-piperidino)-propoxi derivados de indol,indazol,bezimidazol y benzotriazol y sus sales
AR220686A1 (es) Procedimiento para obtener derivados de 2 amino-2-desoxi-3-o-(propilcarbamoilmetil)-carbamoilmetil-glucopiranosa y sus sales
MX4811E (es) Procedimiento para preparar derivados de prostaglandina
AR227556A1 (es) Procedimiento para preparar derivados de 2-fenil-amino-2-imidazolina y sus sales
AR221833A1 (es) Procedimiento para obtener derivados de 1-(3-hidroxipirrolidin-3-ilcarbonilamino o 4-hidroxipiperidin-4-ilcarbonilamino-)-2-(3,5-dihidroxi-4-amino-6 hidroximetil-2,3,5,6-tetrahidropiran-2-iloxi)-3-hidroxi-4-(5-hidroxi-6 aminometil-2,3,5,6-tetrahidropiran-2-iloxi)-5-aminociclohexano y sus sales
AR230280A1 (es) Procedimiento para obtener derivados de carboestirilo y sus sales
AR228144A1 (es) Procedimiento para obtener derivados de 5-fenil-triazolidina-2,4-diona y sus sales
AR218454A1 (es) Procedimiento para preparar derivados de 7-beta-amino o 7-beta-(2-oximino-2-furil o 2-fenilacetamido)-3-(sulfoalquil o 3-sulfoaminalquilo o 3-sulfamilalquil-tetrazol-5-il)tiometil 3-cefem-4-carboxilicos y sus sales
AR222311A1 (es) Procedimiento para preparar derivados de 1,2,3,3 alpha,8,8 alpha,hexahidropirrol-(2,3-b)indol y sus sales
AR213184A1 (es) Procedimiento para preparar derivados de 1,4-etan-6-oxo-perhidroquinoleina y sus sales
SE424553B (sv) Forfarande for framstellning av nya indazol-derivat
AR218951A1 (es) Procedimiento para obtener derivados de acidos 3-(1-metiltetrazolil-tiometil)-7-glicilamido-1-oxadetia-3-cefem-4-carboxilicos y sus sales
AR223160A1 (es) Procedimiento para preparar derivados de 3-aminoalquiltiazolidindiona(2,4)y sus sales
AR218878A1 (es) Procedimiento para preparar derivados de benzopirano y sus sales
AR218247A1 (es) Procedimiento para la obtencion de derivados de 1-(2-aminoetil)-3-(2,6-dihalofenil)-tiourea
AR218452A1 (es) Procedimiento para obtener derivados de 4-(3-(4-piperidil)-propil)-quinoleina y sus sales
AR224610A1 (es) Procedimiento para obtener derivados,de acidos benzacil-benzimidazol-2-carboxilicos o de 2-hidroximetilo y sus sales
AR228036A1 (es) Procedimiento para obtener derivados de 1-tio-alcanoilprolina y sus sales
AR217460A1 (es) Procedimiento para preparar derivados de((alquil-3-isoquinolil-5)-imino)-3-tetrahidro-1, 5, 10,10a-tiazol-(3,4-b)-isoquinoleina y sus sales
AR213853A1 (es) Procedimiento para preparar 7-(alfa-(2,3-dihidro-2-oxo-benzimidazol-1-ilcarbonilamino)-fenilacetamido)-cefalosporina y sus sales
AR217095A1 (es) Procedimiento para preparar derivados de 2-fenil-3-amino-benzo(b)tiofeno y sus sales de adicion de acidos
AR222310A1 (es) Procedimiento para preparar derivados de 5-bencil-(1,2,4)-oxadiazol
MX6120E (es) Procedimiento mejorado para preparar derivados de 1-(3-(3,4,5-trimetoxifenoxi)-2-hidroxipropil)-4-aril-piperazina